DeDora Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
DeDora Capital's BMY Position: Q3 2026 in Review
DeDora Capital opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 514 shares worth $32.1K. The stake represents 0.01% of the portfolio and ranks #212 among its holdings. This is a return to the name: DeDora Capital previously reported a position in BMY as recently as Q2 2023.
DeDora Capital first reported a position in BMY in Q4 2017 and has held it in 17 quarters since. The position peaked at $626K in Q4 2020. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- DeDora Capital held 514 shares of Bristol-Myers Squibb worth $32.1K as of Q3 2026.
- Bristol-Myers Squibb was a new DeDora Capital position in Q3 2026.
- Bristol-Myers Squibb made up 0.01% of DeDora Capital's portfolio in Q3 2026, its #212 holding.
- DeDora Capital first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 17 quarters since.
- DeDora Capital's Bristol-Myers Squibb position peaked at $626K in Q4 2020.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.